Cimzia and Intraocular pressure increased - a phase IV clinical study of FDA data

Summary:

Intraocular pressure increased is reported as a side effect among people who take Cimzia (certolizumab pegol), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Lyrica, and have Glaucoma.

The phase IV clinical study analyzes which people have Intraocular pressure increased when taking Cimzia. It is created by eHealthMe based on reports of 106,367 people who have side effects when taking Cimzia from the FDA, and is updated regularly.

What is Cimzia?

Cimzia has active ingredients of certolizumab pegol. It is often used in rheumatoid arthritis. eHealthMe is studying from 106,745 Cimzia users. Check the latest studies of Cimzia.

What is Intraocular pressure increased?

Intraocular pressure increased is found to be associated with 721 drugs and 954 conditions by eHealthMe. Check the latest studies of Intraocular pressure increased.

On Jul, 16, 2026

106,367 people reported to have side effects when taking Cimzia.
Among them, 14 people (0.01%) have Intraocular pressure increased.

Could Cimzia cause Intraocular pressure increased?

Among these 14 people:

How long have people been on Cimzia when they have Intraocular pressure increased? *

What is the gender of people who have Intraocular pressure increased when taking Cimzia? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Intraocular pressure increased when taking Cimzia? *

What are other drugs people take besides Cimzia? *

What are other side effects people have besides Intraocular pressure increased? *

Dizziness: 7 people, 50.00%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 35.71%
Vision Blurred: 5 people, 35.71%
Drug Ineffective: 4 people, 28.57%
Weight Increased: 3 people, 21.43%
Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 21.43%
Migraine (headache): 3 people, 21.43%
Injection Site Bruising: 3 people, 21.43%
Pericardial Effusion (fluid around the heart): 3 people, 21.43%
High Blood Pressure: 3 people, 21.43%

What are the existing conditions these people have? *

Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 21.43%
Uveitis (inflammation of the uvea): 2 people, 14.29%
High Blood Pressure: 2 people, 14.29%
Breakthrough Pain: 2 people, 14.29%
Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 2 people, 14.29%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 14.29%
Spinal Column Stenosis (narrowing of spinal column): 2 people, 14.29%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 1 person, 7.14%
Bone Loss: 1 person, 7.14%
Urethral Stenosis (narrowing of the urethra, may cause decreased urine output): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Cimzia and have Intraocular pressure increased?

- Check whether Intraocular pressure increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cimzia:

Cimzia (106,745 reports)

Browse all side effects of Cimzia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intraocular pressure increased:

Intraocular pressure increased (721 drugs)

Browse all the conditions that are associated with Intraocular pressure increased:

Intraocular pressure increased (954 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on certolizumab pegol (the active ingredients of Cimzia) and Cimzia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.